The SCARA3 gene helps protect cells from oxidative stress, a type of wear and tear caused by unstable molecules made during normal body processes and illness. This gene plays an important role in helping cells clear damaged molecules when they are under stress. If the SCARA3 gene does not work well, cells may be less able to handle this damage, which can affect how tissues stay healthy. Researchers are also studying SCARA3 variants and reduced SCARA3 activity in some cancers.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing activities in the body. Some genes carry the code for proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. To look into this topic in more detail, you can find more in the LearnHub.
Overview
SCARA3Gene function
What if the gene works
The SCARA3 gene helps cells respond to oxidative stress, a type of damage caused by unstable oxygen molecules. Its protein may help clear harmful oxidized substances and support cell survival under stress.
Risk
What if the gene does not work
If the SCARA3 gene works less well, cells may clear oxidized molecules less effectively and handle oxidative stress poorly. Milder or more severe variants can reduce this protective activity to different degrees.
Treatment
What does that mean for your treatment
No treatment or drug choice approach specific to the SCARA3 gene is currently established for people with a pathogenic variant in this gene. The SCARA3 gene is being studied in cancer and oxidative stress research as a possible biomarker, but this has not changed routine care.
Gene function
What if the gene works
In day to day cell life, the SCARA3 gene helps with cellular cleanup and protection from normal chemical stress. Its protein is part of a receptor family that recognizes altered material on or around cells. Understanding what the SCARA3 gene does in your cells helps show how cells stay balanced over time.
Its protein can recognize and help take in oxidized molecules, which are cell materials changed by normal wear and tear. This supports cleanup around the cell and helps limit buildup of damaged material.
The SCARA3 gene becomes more active during oxidative stress (a buildup of reactive molecules that can strain cells). This added activity helps cells handle everyday chemical wear in a more controlled way.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help account for normal human differences, such as appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more strongly and may contribute to or directly cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SCARA3 gene can alter how much protein a cell makes, how stable that protein is, and how well it folds or interacts with other cell components. Some changes are milder and only partly reduce activity, while more severe variants can sharply lower protein production or create an unstable protein that breaks down sooner. This is the main way SCARA3 gene variants affect protein function at the cellular level.
How variants are linked to conditions
Variants in the SCARA3 gene do not yet have a broadly confirmed link to a specific health condition, though research on SCARA3 gene variants and health conditions is still developing. Anyone with a confirmed SCARA3-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely seen in the general population. Most do not have a direct effect on health and simply represent natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SCARA3 gene. Anyone concerned about personal or family risk can talk with a doctor or genetic counselor.
Inheritance of SCARA3 variants
There is not yet a broadly confirmed disease inheritance pattern tied to the SCARA3 gene, so how SCARA3 gene variants are inherited in relation to a specific health condition is still being clarified. The SCARA3 gene is located on chromosome 8, which is one of the autosomes. That means every person inherits one copy of this gene from their mother and one copy from their father.
What does my SCARA3 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for SCARA3, and this picture may become clearer as research grows. If you have a SCARA3 result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your exact finding and family history.
Genetic information
Genetic testing
How you find out about variants
To look for variants in the SCARA3 gene, a lab usually analyzes DNA from blood or saliva with sequencing, which reads the gene’s code. SCARA3 genetic testing is often included in a multigene panel or exome test, and results may show a benign variant, a variant of uncertain significance, or a pathogenic variant.
When should I consider getting a genetic test?
There is not yet a broadly established, SCARA3-specific reason for genetic testing in routine care. Decisions about testing are usually based on your personal health history, symptoms, and family history, with guidance from a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic findings can be informative, but how much they reveal varies by the condition and the specific variant involved. Over time, how the body works is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help explain individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts at its target. This is common and can help explain why the same treatment works well for one person, seems less helpful for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences can affect a person’s response to medicines. It looks at links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. Additional information on this topic is available in the LearnHub.
Drugs influenced by the SCARA3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or new symptoms are best discussed with your doctor.
History
SCARA3 entered the medical literature in the early 2000s, when researchers identified it as a member of the scavenger receptor family and also referred to it as CSR1. It was first studied in cancer research, where scientists were mapping genes that might help explain why some cells grow in abnormal ways. From these first observations, research expanded steadily. As laboratory methods improved, SCARA3 was linked more clearly to cell stress responses, which helped place it within a broader network of genes involved in protecting cells. SCARA3 has not become a major public facing gene, but its history reflects how many genes move from a laboratory finding to a more defined role in human biology.